SNAI2 and Alzheimer disease: Immunohistochemical analysis revealed a significant upregulation of SNAI2 in AD patients with capCAA (p = 0.038) compared to nondemented controls, while AD patients without capCAA showed only a marginal increase in SNAI2 expression in their vessels (p = 0.052) (Fig. 6A).